A Studio wants to find out from which level of blood pressure antihypertensive treatment should be initiated.
A Studio wants to find out from which level of blood pressure antihypertensive treatment should be initiated. the University Institute of research on attention primary (IDIAP) Jordi Gol, initiates the first study in general population of southern Europe who wants to identify from what level of blood pressure, cardiovascular risk and in relation to the occurrence of cardiovascular episodes antihypertensive treatment is effective in reduction of blood pressure. -the study is new in the sense that for the first time are scanned these values in native and not Anglo-Saxon population – is widely proven that treatment of hypertension is effective to prevent the occurrence of cardiovascular, such as myocardial infarction or stroke events. However, there is considerable controversy regarding the identification of the optimal initial blood pressure level is to start antihypertensive treatment – nor is it clear, once started the treatment, to which values must be reduced blood pressure levels to prevent the occurrence of cardiovascular events -La HTA in Spain presents a prevalence that is between 20% and 47% in the population aged 20 years and generates a high health cost, which in 2001 exceeded 1,144 million euros – data will be obtained from the research platform SIDIAP (information system for the development of research in primary health care) that works with anonymised patient data visited in primary care centres of all Catalonia. consists of a population...
Read More